These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34026352)

  • 1. Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
    Liu J; Zhang H; Zhang J; Bing Z; Wang Y; Li Q; Yang K
    PeerJ; 2021; 9():e11350. PubMed ID: 34026352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses.
    Yang Z; Gong W; Zhang T; Gao H
    Front Oncol; 2021; 11():729137. PubMed ID: 34660294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
    Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
    Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Guo F; Hong J
    Front Genet; 2020; 11():441. PubMed ID: 32431729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.
    Peng P; Chen ZR; Zhang XL; Guo DS; Zhang B; He XM; Wan F
    Curr Med Sci; 2023 Feb; 43(1):156-165. PubMed ID: 36867360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
    Tian Y; Ke Y; Ma Y
    PeerJ; 2020; 8():e9038. PubMed ID: 32509446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a 17-gene signature to improve the survival prediction of gliomas.
    Tong S; Xia M; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Tian D
    Front Immunol; 2022; 13():1000396. PubMed ID: 36248799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
    Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
    CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma.
    Zhang X; Ping S; Wang A; Li C; Zhang R; Song Z; Gao C; Wang F
    Int J Gen Med; 2021; 14():8611-8620. PubMed ID: 34849006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
    Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X
    Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients.
    Guo JC; Wei QS; Dong L; Fang SS; Li F; Zhao Y
    Front Oncol; 2021; 11():644443. PubMed ID: 33768004
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients.
    Li C; Liu F; Sun L; Liu Z; Zeng Y
    BMC Cancer; 2022 Mar; 22(1):230. PubMed ID: 35236310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
    Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B
    Front Oncol; 2021; 11():726745. PubMed ID: 34540695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance.
    Wang QW; Lin WW; Zhu YJ
    Cell Commun Signal; 2022 Jan; 20(1):6. PubMed ID: 35000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.